Product
Quadrivalent RIV with H3 strain 2
1 clinical trial
2 indications
Indication
Influenza ImmunizationIndication
Healthy Control ParticipantsClinical trial
Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens Without or With Adjuvant in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2021-09-20